Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2022 Earnings Call Transcript [Seeking Alpha]
Arcturus Therapeutics Holdings Inc. (ARCT)
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.arcturusrx.com/investor-relations
Company Research
Source: Seeking Alpha
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCTCompany ParticipantsNeda Safarzadeh - IRJoseph Payne - President & CEOAndrew Sassine - CFOPadmanabh Chivukula - Chief Scientific Officer & Chief Operating OfficerConference Call ParticipantsSeamus Fernandez - GuggenheimYanan Zhu - Wells Fargo SecuritiesAshiq Mubarack - CitiPete Stavropoulos - Cantor FitzgeraldOperatorGreetings, and welcome to the Arcturus Therapeutics Fourth Quarter 2022 Financial Update and Pipeline Progress Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.It is now my pleasure to introduce your host, Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations and Marketing. Thank you. You may begin.Thank you, operator. Good afternoon, and welcome to Arcturus Therapeuticsâ?? fourth quarter 2022 financial update and pipeline progress call. Today's cal
Show less
Read more
Impact Snapshot
Event Time:
ARCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARCT alerts
High impacting Arcturus Therapeutics Holdings Inc. news events
Weekly update
A roundup of the hottest topics
ARCT
News
- Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase DeficiencyBusiness Wire
- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $51.00 price target on the stock, up previously from $19.00.MarketBeat
- Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline ProgressBusiness Wire
ARCT
Earnings
- 5/9/23 - Miss
ARCT
Sec Filings
- 5/12/23 - Form 4
- 5/11/23 - Form 144
- 5/10/23 - Form 144
- ARCT's page on the SEC website